The global pipeline of cell therapies for cancer

@article{Yu2019TheGP,
  title={The global pipeline of cell therapies for cancer},
  author={Jia Xin Yu and V. M. Hubbard-Lucey and J. Tang},
  journal={Nature Reviews Drug Discovery},
  year={2019},
  volume={18},
  pages={821-822}
}
  • Jia Xin Yu, V. M. Hubbard-Lucey, J. Tang
  • Published 2019
  • Medicine
  • Nature Reviews Drug Discovery
  • cell therapies to treat CD19-positive haematological cancers have encouraged substantial R&D efforts with cell therapies in oncology. Indeed, cell therapies now represent the largest number of active agents in development in the immunooncology field overall (Nat. Rev. Drug Discov. 17, Trends in the cell therapy landscape Cancer cell therapy platforms and targets. The global cell therapy pipeline includes 1,011 active agents, 258 more than a year ago. Among the different cell therapy types, the… CONTINUE READING

    Figures and Topics from this paper.

    Explore Further: Topics Discussed in This Paper

    Zukunft der onkologischen Pharmakotherapie